Stay updated on Obeldesivir Study in High-risk COVID-19: Clinical Trial
Sign up to get notified when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.

Latest updates to the Obeldesivir Study in High-risk COVID-19: Clinical Trial page
- CheckyesterdayChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1, while the study record remains behind a 403 error.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details, blocking access to the study record. The error page includes a standard header/footer, indicating the page is temporarily inaccessible.SummaryDifference17%

- Check43 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6 on the study record, signaling a minor update to the page's metadata. This change typically reflects small fixes or improvements to the page rather than substantive changes to the study information.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous revision. This indicates a small metadata update to the page rather than any substantive changes to the study details.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a new version of the page content. This is a metadata change rather than a substantive update to study details or outcomes.SummaryDifference0.0%

- Check100 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, signaling a minor site update. It does not modify study details or user-facing functionality.SummaryDifference0.0%

Stay in the know with updates to Obeldesivir Study in High-risk COVID-19: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.